Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SECUKINUMAB vs SELEXIPAG: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SECUKINUMAB vs SELEXIPAG: Safety Overview

Metric SECUKINUMAB SELEXIPAG
Total FAERS Reports 151,223 18,471
Deaths Reported 6,855 3,778
Death Rate 4.5% 20.5%
Hospitalizations 19,098 9,394
Average Patient Age 52.3 yrs 58.4 yrs
% Female Patients 61.9% 71.9%
FDA Approval Date N/A Dec 21, 2015
Manufacturer Novartis Pharmaceuticals Corporation Zydus Pharmaceuticals (USA) Inc.
Route SUBCUTANEOUS ORAL
Marketing Status Prescription Prescription